Which are the causes of Congenital Central Hypoventilation Syndrome?

TL;DR: Congenital Central Hypoventilation Syndrome (CCHS) is primarily caused by a mutation in the PHOX2B gene, which disrupts the autonomic nervous system's ability to regulate breathing during sleep. While it is almost exclusively a genetic condition, research is ongoing to understand how these specific genetic variations translate into the wide spectrum of clinical severity seen in patients.

What causes Congenital Central Hypoventilation Syndrome?

At its core, Congenital Central Hypoventilation Syndrome is a disorder of autonomic control. Think of the brain's breathing center as a thermostat that is supposed to automatically turn on the "ventilation" fan when carbon dioxide levels rise in the blood. In individuals with Congenital Central Hypoventilation Syndrome, this thermostat is broken or fails to send the signal to the lungs to breathe, particularly during sleep or quiet rest, because the brainstem's respiratory control centers do not respond correctly to chemical changes in the body.

Is Congenital Central Hypoventilation Syndrome hereditary?

Congenital Central Hypoventilation Syndrome is almost always caused by a mutation in the PHOX2B gene located on chromosome 4. This gene acts as a "master switch" for the development of the autonomic nervous system. Most cases occur as a de novo mutation, meaning the genetic change happens spontaneously in the child and is not inherited from either parent. However, in a small percentage of cases, a parent may carry the mutation in a mosaic state (where only some body cells have the mutation) and pass it to their offspring. Because of this, clinical genetic testing is essential for families navigating Congenital Central Hypoventilation Syndrome.

How do PHOX2B mutations affect the body?

The PHOX2B gene contains a segment of repeated DNA sequences known as polyalanine repeats. In healthy individuals, there are 20 repeats. In Congenital Central Hypoventilation Syndrome, this number increases, a phenomenon called a polyalanine repeat expansion mutation (PARM). The severity of the symptoms often correlates with the length of these repeats:

• 20 repeats: Normal function.


• 24–33 repeats: Generally associated with Congenital Central Hypoventilation Syndrome; longer repeats often correlate with a need for 24-hour ventilatory support.


• Missense mutations: These are non-repeat mutations that can lead to more severe forms of the condition, sometimes involving issues beyond breathing, such as Hirschsprung disease or tumors of the neural crest (neuroblastoma).

Are there environmental or other triggers?

Currently, there is no evidence that environmental factors, infections, or toxins cause Congenital Central Hypoventilation Syndrome. It is strictly a genetic neurodevelopmental condition. It is important to distinguish between "causes" and "risk factors"—a cause is the direct genetic error that creates the disease, whereas a risk factor would be an external influence that increases the likelihood of the disease occurring. Since this condition is genetic, there are no known lifestyle or environmental modifications that can prevent the onset of Congenital Central Hypoventilation Syndrome.

What is the focus of current research?

Medical researchers are currently studying how PHOX2B influences the development of specific neurons in the brainstem. By mapping these pathways, scientists hope to eventually develop pharmacological therapies that might one day "wake up" the respiratory drive. At DiseaseMaps.org, where 94 people with Congenital Central Hypoventilation Syndrome have shared their experiences, this community-driven data helps researchers understand the real-world variability in how these genetic mutations manifest across different ages and environments.

Next steps

• Consult with a clinical geneticist to undergo PHOX2B mutation analysis.


• Seek a referral to a specialized pediatric pulmonologist or neurologist familiar with CCHS.


• Connect with the community at DiseaseMaps.org to share experiences and learn from others living with the condition.


• Monitor for associated autonomic issues, such as Hirschsprung disease or ocular abnormalities, as recommended by your specialist.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with a qualified healthcare professional regarding any medical diagnosis or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Information on Congenital Central Hypoventilation Syndrome.


• OMIM (Online Mendelian Inheritance in Man): Entry #209880 regarding PHOX2B-related disorders.


• Orphanet: The portal for rare diseases and orphan drugs, detailing the clinical presentation of CCHS.


• CCHS Network: International patient advocacy and support resource for families.